Thu, Aug 21, 2014, 9:10 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

atpl1959 6 posts  |  Last Activity: Jul 11, 2014 12:40 PM Member since: Dec 2, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    UBS Upgrade of SGEN To Buy Today With PT of $48

    by ricardouno Jul 9, 2014 7:15 AM
    atpl1959 atpl1959 Jul 11, 2014 12:40 PM Flag

    Are you trying to convince the reader that slower than expected event occurrence is a bad thing ?
    The reason the events aren't occurring is because the treatment is working even better than the experts would have expected when the trial was designed. The event in PFS is progression. No progression , no event occurrence. Why spin that data to imply it's bad. Sooner rather than later SGEN and Takeda take the data to the FDA. They look at it and say " Why delay further, lives are being saved, we've seen enough without having to wait any longer".
    Grow up man and stop coming out with your nonsense every time the stock makes a decent move and you are caught on the wrong side of your trade.

  • Reply to

    Siegalls form 4

    by dpemco Jun 13, 2014 12:14 PM
    atpl1959 atpl1959 Jun 16, 2014 7:35 PM Flag

    What is your take ?
    The 10b5-1 plan sale indicates the sale was made while having some inside information, however the same day acquisition and sale of this reduced price stock by Clay is in line with past performance of his.
    I find the very large disposition via gift as more intriguing . If he is married, this large gift is somewhat in line for a lifetime gift tax exclusion. He will pay no taxes as the donor of the gift.
    The recipient only would have to pay capital gains on the increase in value as of the date the gift is made.
    For example, let's say Clay has been fielding offers for Sgen, I.e. Inside info
    It certainly would make sense if one were considering a sale to gift away a rather large amount of shares to someone close so the lifetime exemption would prevent the cap gains on those shares being taxed to the donor, while the recipients cost basis vis a vis cap gains would only be calculated as of the day of the gift.

    I don't know, but this rather large gift at a time the Baker are very intent on accumulating is interesting.
    What is your take ?

  • atpl1959 atpl1959 Jun 4, 2014 10:16 AM Flag

    I forgot to add,
    this is the SGEN message board where some come to get information on a stock they have invested in. While I can sympathize with your plight and anger at the system, there are better places than this to direct your anger. Try writing one of our do nothing congressmen and demand some action. This system is under their jurisdiction and they simply are content to ignore the situation or turn it into party bashing talking points. Accept the fact that instead of a Democracy we really live in a 2 headed dictatorship where our elected officials simply act for the good of their party rather than the good of the people.

  • atpl1959 atpl1959 Jun 4, 2014 10:05 AM Flag

    Just to clarify,

    Obamacare is not free. It is a system set up so that individuals can purchase health insurance so that they can stop overloading the Emergency rooms across this country because they are not insured.

    The VA system is free healthcare.
    That then becomes a problem due to the fact we have so many more veterans now than the system was ever meant to handle. Rather than pumping money into a system that doesn't work and never will in this day and age, I can see subsidizing and making affordable the purchase of private health insurance for our veterans that have been injured in the line of duty. Those veterans that have gone on to paying jobs in the private sector should get insurance under Obamacare with some governmental offsetting of the cost, if necessary.

    People in this country should not die waiting on healthcare but don't just adopt the FOX News talking point of the day and think it addresses the problem.

  • Reply to

    Conference call........!?

    by christianegeskov May 23, 2014 8:51 AM
    atpl1959 atpl1959 May 23, 2014 11:22 AM Flag

    My guess this is set up to pitch Clay some softballs regarding the ASCO data to fully explain why they are attempting to renegotiate the endpoints in the Echelon study as it is pretty ridiculous to keep going on until all endpoints have been reached and thereby denying patients access to the optimal frontline treatment out there, Adcetris.
    As well as to explain and add to some of the data with some of the other abstracts. These abstracts had to be submitted by Feb 4th for acceptance which means they were written well before that date. I assume there probably is some additional data that can be reported.
    Two of the papers submitted to ASCO re Adcetris were chosen as the best of ASCO. The one on SGN CD19A as well as a study out of Italy in treatment naïve HL pts that were given 2 cycles of Adcetris before the std. ABVD regimen. Of the 12 patients they were hoping to get responses from 10. They actually ended up with response from 11 of the 12 patients. 10 of the responses after only 2 cycles were complete responses. 1 partial metabolic response.
    The only patient that did not respond to 2 cycles was a pt. with St. III disease at the time of treatment.
    Of the 11 St. II patients , 7 were early favorable, and 4 were early unfavorable charachteristics of the HL.

    The move to Frontline is on and the data supports it.

  • Reply to

    Conference call........!?

    by christianegeskov May 23, 2014 8:51 AM
    atpl1959 atpl1959 May 23, 2014 9:34 AM Flag

    The day before ASCO begins.

42.50-0.49(-1.14%)Aug 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.